文献速递类风湿关节炎

早期类风湿关节炎治疗决策的变异及其影响:全国队列研究结果

Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该全国性审计纳入136个科室的7154例RA患者,分析早期治疗选择与3个月治疗反应的关系。结果显示各科室处方选择差异大且偏离指南,超过75%患者使用糖皮质激素,不足一半使用联合传统DMARDs;早期糖皮质激素治疗与良好治疗反应相关(OR 1.93,95%CI 1.31–2.84,P=0.001)。

要点

  • 各科室早期RA处方选择差异大,不能仅用病例组合解释。
  • 超过75%患者接受糖皮质激素,不足一半接受联合传统DMARDs。
  • 早期糖皮质激素治疗与3个月良好治疗反应独立相关。

核心结论

  • 各科室对早期RA指南的依从性存在差异且不能仅由病例组合解释。
  • 早期加用糖皮质激素的科室获得更好的短期治疗结局。

研究设计与样本

  • 全国性RA审计,从136个科室招募7154例确诊RA患者。
  • 基线收集治疗选择、DAS和社会人口学因素,3个月评估治疗反应。
  • 采用多水平回归模型刻画处方科室差异,热图展示地理变异。
  • 采用混合效应回归模型评估治疗决策与疾病结局的关系,并调整患者和科室层面协变量。

主要发现

  • 处方选择存在广泛变异,即使相邻科室之间也如此,并有明显偏离指南的证据。
  • 超过75%的患者接受了糖皮质激素,不足一半接受了联合传统DMARDs。
  • 早期糖皮质激素治疗与获得良好治疗反应相关(OR 1.93,95%CI 1.31–2.84,P=0.001)。
  • 倾向性模型和插补后该关联仍然存在。

临床怎么用

  • 早期RA治疗中可考虑早期加用糖皮质激素以改善短期治疗反应。
  • 需关注本科室处方与指南的差距,减少不能由病例组合解释的变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Trial data have provided an evidence base to guide early treatment in RA. Few studies have investigated rheumatologists' adherence to guidelines, and subsequent impact on outcomes. The objectives of this study are to characterize baseline prescribing for patients with RA across the National Health Service, identifying treatment decisions that associate with patient outcomes. METHODS: A nationwide audit of RA collected information on treatment choices, DAS and sociodemographic factors at baseline. Treatment response was assessed at 3 months. Multilevel regression models were used to characterize departmental variations in prescribing. Heat maps were used to visualize geographical variation. Mixed effects regression models were constructed to assess the relationship between treatment decisions and disease outcomes, adjusting for patient and department level covariates. RESULTS: A total of 7154 patients with a diagnosis of RA were recruited from 136 departments. There was broad variation in prescribing choices, even between departments close to one another, with evidence of substantial deviation from guidelines. Over 75% of patients received glucocorticoids, fewer than half received combination conventional DMARDs. Early glucocorticoid therapy associated with achieving a good treatment response [odds ratio 1.93 (95% CI 1.31, 2.84), P-value = 0.001]. The association was maintained following propensity modelling and imputation. CONCLUSION: Guideline adherence varies between departments and cannot be explained by case-mix alone. Departments that prescribe early adjunctive steroid achieve better short-term outcomes. Further research should work to ensure that the early arthritis evidence base translates into better outcomes for patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yates M, MacGregor AJ, Ledingham J, et al. Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study. Rheumatology (Oxford). 2020. PMID: 31803913. doi:10.1093/rheumatology/kez550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。